Latest Japan Approvals Include Entyvio, Imfinzi, World-First Indication

 
• By Ian Haydock

Takeda’s global blockbuster GI drug Entyvio has been approved in Japan, although its local sales prospects appear limited, while two novel cancer drugs from AstraZeneca and a world-first indication have also been cleared by the health ministry.

Japanese flag
NEW JAPAN APPROVALS INCLUDE ENTYVIO, IMFINZI • Source: Shutterstock

More from Japan

More from Asia